Area of research
Immunology · Cancer Research
Research interest
Research interests include Immune Cell Function and Interaction, Cancer-related molecular mechanisms research, T-cell and B-cell Immunology, and Immunotherapy and Immune Responses.
1953P PLB-1004 in advanced non-small cell lung cancer (NSCLC) with exon 20 insertion mutations (ex20ins): A multicenter, single-arm, phase II study
Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells.
An open-label phase II study of dostarlimab (TSR-042), bevacizumab (bev), and niraparib combination in patients (pts) with platinum-resistant ovarian cancer (PROC): cohort A of the OPAL trial
Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice
International consensus on severe lung cancer—the first edition
PD-1 Protects Liver Damage by Suppressing IFN-γ Expression in T Cells in Infants and Neonatal Mice
Brain Homotopic Connectivity in Mild Cognitive Impairment APOE-ε4 Carriers
Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1<sup>high</sup> memory phenotype CD4 T cells.
Long Non-coding RNA LINC00628 Interacts Epigenetically with the LAMA3 Promoter and Contributes to Lung Adenocarcinoma
Circulating tumor DNA analysis to reveal genomic profiles for epithelial ovarian cancer.
Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers
Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo
Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation